CoChat

Standard Operating Procedures for Peyronie's Disease

Levine, Laurence A., Burnett, Arthur L. · 2013 · The Journal of Sexual Medicine
Cited by 134

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Introduction: Peyronie's disease (PD) refers to a penile deformity that is associated with sexual dysfunction. Aim: To provide recommendations and Standard Operating Procedures (SOPs) based on best evidence for diagnosis and treatment of PD. Methods: Medical literature was reviewed and combined with expert opinion of the authors. Main Outcome Measures: Recommendations and SOPs based on grading of evidence–based medical literature. Results: PD is a fibrotic wound-healing disorder involving the tunica albuginea of the corpora cavernosa. The resulting scar is responsible for a variety of deformities, including curvature, shortening, narrowing with hinge effect, and is frequently associated in the early phase with pain. Patients frequently experience diminished quality erections. All of these conditions can compromise sexual function for the affected male. The etiopathophysiology of PD has yet to be clarified and as a result, effective, reliable, mechanistic directed non-surgical therapy is lacking. Conclusions: The management of PD consists of proper diagnosis and treatment, ranging from non-surgical to surgical interventions. The main state of treatment for PD rests at this time on surgical correction that should be based on clear indications, involve surgical consent, and follow a surgical algorithm that includes tunica plication, plaque incision/partial excision and grafting, and penile prosthesis implantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1743-6109.2012.03003.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 98

  1. Schwarzer, 2001, The prevalence of Peyronie's disease: Results of a large survey, BJU Int, 88, 727, 10.1046/j.1464-4096.2001.02436.x · DOI · Paper page
  2. Mulhall, 2004, Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening, J Urol, 171, 2350, 10.1097/01.ju.0000127744.18878.f1 · DOI · Paper page
  3. Kadioglu, 2002, A retrospective review of 307 men with Peyronie's disease, J Urol, 168, 1075, 10.1016/S0022-5347(05)64578-8 · DOI · Paper page
  4. Levine, 2003, Establishing a standardized evaluation of the man with Peyronies's disease, Int J Impot Res, 15, S103, 10.1038/sj.ijir.3901083 · DOI
  5. Hellstrom, 2012, Phase 3 Study of CCH in Patients with Peyronie's disease: Development and validation of the Peyronie's Disease Questionnaire (PDQ)
  6. Bacal, 2009, Correlation of degree of penile curvature between patient estimates and objective measures among men with Peyronies's disease, J Sex Med, 6, 862, 10.1111/j.1743-6109.2008.01158.x · DOI · Paper page
  7. Benson, 2009, Penile shortening after radical prostatectomy and Peyronie's surgery, Curr Urol Rep, 10, 468, 10.1007/s11934-009-0074-z · DOI
  8. Wessells, 1996, Penile length in the flaccid and erect states: Guidelines for penile augmentation, J Urol, 156, 995, 10.1016/S0022-5347(01)65682-9 · DOI · Paper page
  9. Moreno, 2009, Testosterone deficiency and Peyronie's disease: Pilot data suggesting a significant relationship, J Sex Med, 6, 1729, 10.1111/j.1743-6109.2009.01250.x · DOI · Paper page
  10. Rhoden, 2010, A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie's disease, J Sex Med, 7, 1529, 10.1111/j.1743-6109.2009.01584.x · DOI · Paper page
  11. Montorsi, 1994, Vascular abnormalities in Peyronie's disease: The role of color Doppler sonography, J Urol, 15, 373, 10.1016/S0022-5347(17)34952-2 · DOI
  12. Lopez, 1993, Penile vascular evaluation of men with Peyronie's disease, J Urol, 149, 53, 10.1016/S0022-5347(17)35997-9 · DOI · Paper page
  13. Corder, 2011, Calcified Peyronie's plaques: Prevalence, presentation and treatment selection. Proceedings from the 16th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America. Poster # 41, J Sex Med, 8, 4
  14. Hellstrom, 2009, Medical management of Peyronie's disease, J Androl, 30, 397, 10.2164/jandrol.108.006221 · DOI
  15. Ralph, 2010, The medical management of Peyronie's disease: Evidence-based 2010 guidelines, J Sex Med, 7, 2359, 10.1111/j.1743-6109.2010.01850.x · DOI · Paper page
  16. Larsen, 2011, Peyronie's disease: Review of nonsurgical treatment options, Urol Clin North Am, 38, 195, 10.1016/j.ucl.2011.02.006 · DOI
  17. Schaeffer, 2012, Non-surgical interventions for Peyronie's disease: 2011 Update, J Androl, 33, 3, 10.2164/jandrol.110.010561 · DOI
  18. Pryor, 1983, Controlled clinical trial of vitamin E in Peyronie's disease, Prog Reprod Biol, 9, 41
  19. Safarinejad, 2007, Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: A double-blind, placebo-controlled, randomized study, J Urol, 178, 1398, 10.1016/j.juro.2007.05.162 · DOI · Paper page
  20. Safarinejad, 2004, Therapeutic effects of colchicine in the management of Peyronie's disease: A randomized double-blind, placebo-controlled study, Int J Impot Res, 16, 238, 10.1038/sj.ijir.3901185 · DOI
  21. Prieto Castro, 2003, Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease, BJU Int, 91, 522, 10.1046/j.1464-410X.2003.04134.x · DOI · Paper page
  22. Weidner, 2005, Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: A perspective, placebo-controlled, randomized study, Eur Urol, 47, 530, 10.1016/j.eururo.2004.12.022 · DOI · Paper page
  23. Teloken, 1999, Tamoxifen versus placebo in the treatment of Peyronie's disease, J Urol, 162, 2003, 10.1016/S0022-5347(05)68087-1 · DOI · Paper page
  24. Safarinejad, 2010, A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease, BJU Int, 106, 240, 10.1111/j.1464-410X.2009.09041.x · DOI · Paper page
  25. Valente, 2003, L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronies's fibrotic plaque and related fibroblast cultures, Nitric Oxide, 9, 229, 10.1016/j.niox.2003.12.002 · DOI · Paper page
  26. Montorsi, 2004, Review of phosphodiesterases in the urogenital system: New directions for therapeutic intervention, J Sex Med, 1, 322, 10.1111/j.1743-6109.04047.x · DOI
  27. Gelbard, 1993, Collagenase versus placebo in the treatment of Peyronie's disease: A double-blind study, J Urol, 149, 56, 10.1016/S0022-5347(17)35998-0 · DOI · Paper page
  28. Jordan, 2008, The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: A prospective, single-center, non-placebo-controlled study, J Sex Med, 5, 180, 10.1111/j.1743-6109.2007.00651.x · DOI · Paper page
  29. Gelbard, 2012, Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie's disease, J Urol, 187, 2268, 10.1016/j.juro.2012.01.032 · DOI · Paper page
  30. Levine, 1994, Intralesional verapamil injection for the treatment of Peyronie's disease, J Urol, 151, 1522, 10.1016/S0022-5347(17)35291-6 · DOI · Paper page
  31. Levine, 2002, Experience with intraplaque injection of verapamil for Peyronie's disease, J Urol, 168, 621, 10.1016/S0022-5347(05)64691-5 · DOI · Paper page
  32. Rehman, 1998, Use of intralesional verapamil to dissolve Peyronie's disease plaque: A long-term single-blind study, Urology, 51, 620, 10.1016/S0090-4295(97)00700-0 · DOI · Paper page
  33. Bennett, 2007, Intralesional verapamil prevents the progression of Peyronie's disease, Urology, 69, 1181, 10.1016/j.urology.2007.02.042 · DOI
  34. Cavallini, 2007, Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease, Urology, 69, 950, 10.1016/j.urology.2007.01.080 · DOI
  35. Shirazi, 2009, Effect of intralesional verapamil for treatment of Peyronie's disease: A randomized single-blind, placebo-controlled study, Int Urol Nephrol, 41, 467, 10.1007/s11255-009-9522-4 · DOI
  36. Soh, 2010, Nicardipine vs. saline injection as treatment for Peyronie's disease: A prospective, randomized, single-blind trial, J Sex Med, 7, 3743, 10.1111/j.1743-6109.2010.01924.x · DOI · Paper page
  37. Hellstrom, 2006, Single-blind, multicenter, placebo-controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease, J Urol, 176, 394, 10.1016/S0022-5347(06)00517-9 · DOI · Paper page
  38. Inal, 2006, Effect of intralesional interferon-alpha 2b with oral vitamin E for treatment of early stage Peyronie's disease: A randomized and prospective study, Urology, 67, 1038, 10.1016/j.urology.2005.11.005 · DOI
  39. Martin, 2002, Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea, J Urol, 168, 2483, 10.1016/S0022-5347(05)64173-0 · DOI · Paper page
  40. Riedl, 2000, Iontophoresis for treatment of Peyronie's disease, J Urol, 163, 95, 10.1016/S0022-5347(05)67981-5 · DOI
  41. Di Stasi, 2004, A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease, J Urol, 171, 1605, 10.1097/01.ju.0000116450.82816.2c · DOI · Paper page
  42. Greenfield, 2007, Verapamil versus saline in electromotive drug administration for Peyronie's disease: A double-blind, placebo-controlled trial, J Urol, 177, 972, 10.1016/j.juro.2006.10.065 · DOI · Paper page
  43. Hauck, 2004, Extracorporeal shock wave therapy for Peyronie's disease: Exploratory meta-analysis of clinical trials, J Urol, 171, 740, 10.1097/01.ju.0000108060.30363.8d · DOI · Paper page
  44. Palmieri, 2009, A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease, Eur Urol, 56, 363, 10.1016/j.eururo.2009.05.012 · DOI · Paper page
  45. Levine, 2008, Penile traction therapy for treatment of Peyronie's disease: A single-center pilot study, J Sex Med, 5, 1468, 10.1111/j.1743-6109.2008.00814.x · DOI · Paper page
  46. Gontero, 2009, Use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease. Results of a phase II prospective study, J Sex Med, 6, 558, 10.1111/j.1743-6109.2008.01108.x · DOI · Paper page
  47. Fricke, 1948, Peyronie's disease and its treatment with radium, J Urol, 59, 627, 10.1016/S0022-5347(17)69421-7 · doi:10.1016/s0022-5347(17)69421-7
  48. Incrocci, 2000, Low-dose radiotherapy in 179 patients with Peyronie's disease: Treatment outcome and current sexual functioning, Int J Radiat Oncol Biol Phys, 47, 1353, 10.1016/S0360-3016(00)00505-8 · DOI
  49. Rybak, 2012, Does Calcification of Peyronie's disease plaque predict progression to surgical correction? Presented at the 2012 Annual Meeting of the American Urological Association
  50. Jordan, 2007, Peyronie's disease, Campbell-Walsh urology, 818
  51. Taylor, 2007, Peyronie's disease, Urologic clinics of North America, 818
  52. Taylor, 2008, Surgical correction of Peyronie's disease via tunica albuginea plication or partial plaque excision with pericardial graft: Long-term follow-up, J Sex Med, 5, 2221, 10.1111/j.1743-6109.2008.00941.x · DOI · Paper page
  53. Ralph, 2004, The management of Peyronie's disease, BJU Int, 93, 208, 10.1111/j.1464-410X.2004.04587.x · DOI · Paper page
  54. Mulhall, 2005, A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction. Functional and satisfaction outcomes, J Sex Med, 2, 132, 10.1111/j.1743-6109.2005.20113.x · DOI · Paper page
  55. Taylor, 2012, Predicting erectile dysfunction following surgical correction of Peyronie's disease without inflatable penile prosthesis placement: Vascular assessment and preoperative risk factors, J Sex Med, 9, 296, 10.1111/j.1743-6109.2011.02460.x · DOI · Paper page
  56. Andrews, 1999, The Nesbit operation for congenital curvature of the penis, Int J Impot Res, 11, 119, 10.1038/sj.ijir.3900390 · doi:10.1038/sj.ijir.3900390
  57. Yachia, 1990, Modified Corporoplasty for the treatment of penile curvature, J Urol, 143, 80, 10.1016/S0022-5347(17)39871-3 · DOI · Paper page
  58. Gholami, 2002, Correction of penile curvature using the 16-dot plication technique: A review of 132 patients, J Urol, 167, 2066, 10.1016/S0022-5347(05)65085-9 · DOI · Paper page
  59. Brant, 2007, 16-dot procedure for penile curvature, J Sex Med, 2, 277, 10.1111/j.1743-6109.2007.00429.x · DOI
  60. Baskin, 1994, Dorsal tunica albuginea plication for hypospadius curvature, J Urol, 151, 1668, 10.1016/S0022-5347(17)35341-7 · DOI · Paper page
  61. Levine, 2006, Penile straightening with tunica albuginea plication procedure: TAP procedure, Peyronie's disease: A guide to clinical management, 151
  62. Greenfield, 2006, Factors affecting the loss of length associated with tunical albuginea plication for correction of penile curvature, J Urol, 175, 238, 10.1016/S0022-5347(05)00063-7 · DOI · Paper page
  63. Alphs, 2010, Preoperative clinical and diagnostic characteristics of patients who require delayed IPP after primary Peyronie's repair, J Sex Med, 7, 1262, 10.1111/j.1743-6109.2009.01649.x · doi:10.1111/j.1743-6109.2009.01649.x
  64. Levine, 2005, Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction, J Sex Med, 2, 241, 10.1111/j.1743-6109.2005.20234.x · DOI · Paper page
  65. Gelbard, 1995, Relaxing incisions in the correction of penile deformity due to Peyronie's disease, J Urol, 154, 1457, 10.1016/S0022-5347(01)66891-5 · DOI · Paper page
  66. Egydio, 2004, A single relaxing incision to correct different types of penile curvature: Surgical technique based on geometrical principles, BJU Int, 94, 1147, 10.1111/j.1464-410X.2004.05220.x · DOI
  67. Kadioglu, 2007, Graft materials in Peyronie's disease surgery: A comprehensive review, J Sex Med, 4, 581, 10.1111/j.1743-6109.2007.00461.x · DOI · Paper page
  68. Lowsley, 1950, Further experiences with an operation for the cure of Peyronie's disease, J Urol, 63, 888, 10.1016/S0022-5347(17)68843-8 · DOI
  69. Devine, 1974, Surgical treatment of Peyronie's disease with a dermal graft, J Urol, 111, 44, 10.1016/S0022-5347(17)59886-9 · DOI · Paper page
  70. Das, 1980, Peyronie's disease: Excision and autografting with tunica vaginalis, J Urol, 124, 818, 10.1016/S0022-5347(17)55682-7 · doi:10.1016/s0022-5347(17)55682-7
  71. Sampaio, 2002, Peyronie's disease. Surgical correction of 40 patients with relaxing incision and dura mater graft, Eur Urol, 41, 551, 10.1016/S0302-2838(02)00071-4 · DOI
  72. Burnett, 1997, Fascia lata in penile reconstructive surgery: A reappraisal of the fascia lata graft, Plast Reconstr Surg, 99, 1061, 10.1097/00006534-199704000-00021 · doi:10.1097/00006534-199704000-00021
  73. Lue, 1998, Venous patch graft for Peyronie's disease. Part I: Technique, J Urol, 160, 2047, 10.1016/S0022-5347(01)62239-0 · DOI · Paper page
  74. Teloken, 2000, Penile straightening with crural graft of the corpus cavernosum, J Urol, 164, 107, 10.1016/S0022-5347(05)67459-9 · DOI
  75. Shioshvili, 2005, The surgical treatment of Peyronie's disease: Replacement of plaque by free autograft of buccal mucosa, Eur Urol, 48, 129, 10.1016/j.eururo.2005.01.018 · DOI
  76. Brannigan, 1998, Comparison of tunica albuginea substitutes for the treatment of Peyronie's disease, J Urol, 159, 1064, 10.1016/S0022-5347(01)63836-9 · DOI
  77. Hellstrom, 2000, Application of pericardial graft in the surgical management of Peyronie's disease, J Urol, 163, 1445, 10.1016/S0022-5347(05)67639-2 · DOI
  78. Knoll, 2007, Use of small intestinal submucosa graft for the surgical management of Peyronie's disease, J Urol, 178, 2474, 10.1016/j.juro.2007.08.044 · DOI
  79. John, 2006, Porcine small intestinal submucosa is not an ideal graft material for Peyronie's disease surgery, J Urol, 176, 1025, 10.1016/j.juro.2006.04.039 · DOI
  80. Breyer, 2007, Complications of porcine small intestine submucosa graft for Peyronie's disease, J Urol, 177, 589, 10.1016/j.juro.2006.09.051 · DOI · Paper page
  81. Kovac, 2007, Surgical outcomes and patient satisfaction after dermal, pericardial, and small intestinal submucosal grafting for Peyronie's disease, J Sex Med, 4, 1500, 10.1111/j.1743-6109.2007.00453.x · DOI · Paper page
  82. Chung, 2011, Five-year follow-up of Peyronie's graft surgery: Outcomes and patient satisfaction, J Sex Med, 8, 594, 10.1111/j.1743-6109.2010.02102.x · DOI · Paper page
  83. Levine, 2011, Partial plaque excision and grafting (PEG) for Peyronie's disease, J Sex Med, 8, 1842, 10.1111/j.1743-6109.2011.02370.x · DOI
  84. Dalkin, 1991, Venogenic impotence following dermal graft repair for Peyronie's disease, J Urol, 146, 849, 10.1016/S0022-5347(17)37941-7 · DOI · Paper page
  85. Garaffa, 2010, Circumcision is not mandatory in penile surgery, BJU Int, 105, 222, 10.1111/j.1464-410X.2009.08763.x · DOI
  86. Horton, 1987, Peyronie's disease, Ann Plast Surg, 18, 122, 10.1097/00000637-198702000-00005 · doi:10.1097/00000637-198702000-00005
  87. Moncada-Iribarren, 2007, Managing penile shortening after Peyronie's Disease Surgery
  88. Levine, 2011, A comparative analysis of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie's disease: Measured lengths and patient perceptions
  89. Kalsi, 2005, The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's Disease, BJU Int, 95, 1029, 10.1111/j.1464-410X.2005.05459.x · DOI · Paper page
  90. Montorsi, 2004, Five-year follow-up of plaque incision and vein grafting for Peyronie's disease, J Urol, 171, 331, 10.1016/S0022-5347(18)38481-7 · doi:10.1016/s0022-5347(18)38481-7
  91. Wilson, 1994, A new treatment for Peyronie's disease: Modeling the penis over an inflatable penile prosthesis, J Urol, 152, 1121, 10.1016/S0022-5347(17)32519-3 · DOI · Paper page
  92. Montorsi, 1993, Patient–partner satisfaction with semirigid penile prostheses for Peyronie's disease: A 5-year follow-up study, J Urol, 150, 1819, 10.1016/S0022-5347(17)35904-9 · DOI · Paper page
  93. Wilson, 2001, Long-term follow-up of treatment for Peyronie's disease: Modeling the penis over an inflatable penile prosthesis, J Urol, 165, 825, 10.1016/S0022-5347(05)66537-8 · DOI · Paper page
  94. Rahman, 2004, Combined penile plication surgery and insertion of penile prosthesis for severe penile curvature and erectile dysfunction, J Urol, 171, 2346, 10.1097/01.ju.0000124042.74905.70 · doi:10.1097/01.ju.0000124042.74905.70
  95. Hakim, 1996, Guide to safe corporotomy incisions in the presence of underlying inflatable penile cylinders: Results of in vitro and in vivo studies, J Urol, 155, 918, 10.1016/S0022-5347(01)66346-8 · DOI
  96. Akin-Olugbade, 2006, Determinants of patients satisfaction following penile prosthesis surgery, J Sex Med, 3, 743, 10.1111/j.1743-6109.2006.00278.x · DOI · Paper page
  97. Montague, 2007, Penile prosthesis implantation: Size matters, Eur Urol, 51, 887, 10.1016/j.eururo.2006.10.027 · doi:10.1016/j.eururo.2006.10.027
  98. Levine, 2011, Traction therapy for men with shortened penis prior to penile prosthesis implantation: A pilot study, J Sex Med, 8, 2112, 10.1111/j.1743-6109.2011.02285.x · DOI

Cited by

See all 134

Metadata

Authors
Levine, L. A., & Burnett, A. L.
Venue
The Journal of Sexual Medicine
Published
2013-01-01
Volume
10
Issue
1
Pages
230-244
ISSN
  • 1743-6095 (ISSN-L)
  • 1743-6109
OpenAlex
W1943230436
Cited by
134
References
8
FWCI
6.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Standard Operating Procedures for Peyronie's Disease. https://app.cochat.ai/papers/10.1111/j.1743-6109.2012.03003.x
The paper
Levine, L. A., & Burnett, A. L. (2013). Standard Operating Procedures for Peyronie's Disease. The Journal of Sexual Medicine. https://doi.org/10.1111/j.1743-6109.2012.03003.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.